News by Subject Medicine & Health

A Scientific E-Poster to be presented at the 2021 ARRS Virtual Annual Meeting found the COVID-19 'Safer at Home' order resulted in a significant decline in radiology ordering utilization, outpatient consultations, and emergency department (ED) visits.

A targeted opioid that only treats diseased tissues and spares healthy tissues relieves pain from inflammatory bowel disease without causing side effects, according to new research published in the journal Gut.

Revealing a mechanism by which diets rich in ultra-processed foods damage our health, experiments with rats established that certain compounds, which form when food is heat-treated during production, increase the risk of diseases such as chronic kidney disease. The study found that regularly eating foods cooked or processed at high temperatures, including roast meats,

New study identifies a novel approach for tailored treatment that could be more effective for patients with the chronic disease

In a randomized clinical trial published in the journal PAIN, researchers found participants with moderate to severe irritable bowel syndrome (IBS) who were knowingly treated with a pharmacologically inactive pill -- referred to as an honest or open-label placebo -- reported clinically meaningful improvements in their IBS symptoms.

Primary sclerosing cholangitis (PSC) is a rare, chronic, inflammatory disease of the bile ducts and is difficult to treat, since its causes have not yet been adequately researched. An international research consortium led by MedUni Vienna has now succeeded in identifying a new prognostic factor for PSC from liver biopsies. This is so-called cellular ER stress.

Using patient data from multiple locations, scientists used mathematical models to estimate an "eliciting dose" -- or the amount of peanut protein that will cause or elicit an allergic reaction in a certain percentage of peanut sensitive patients.